open access: BMJ - Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

Effect of hormone replacement therapy oncardiovascular events in recently postmenopausalwomen: randomised trial 

Conclusions
After 10 years of randomised treatment, women receiving
hormone replacement therapy early after menopause had a significantly
reduced risk of mortality, heart failure, or myocardial infarction, without
any apparent increase in risk of cancer, venous thromboembolism, or
stroke.

Trial registration ClinicalTrials.gov NCT00252408.